Western Financial Corp’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$614K Buy
4,860
+297
+7% +$39.1K 0.18% 91
2026
Q1
$636K Buy
4,563
+616
+16% +$86.3K 0.25% 82
2025
Q4
$484K Sell
3,947
-111
-3% -$13.5K 0.19% 88
2025
Q3
$450K Sell
4,058
-597
-13% -$67.9K 0.2% 94
2025
Q2
$516K Sell
4,655
-5,247
-53% -$558K 0.28% 87
2025
Q1
$1.11M Buy
+9,902
New +$1.02M 0.64% 44
2023
Q3
Sell
-6,162
Closed -$475K 112
2023
Q2
$475K Buy
6,162
+794
+15% +$63.3K 0.32% 85
2023
Q1
$445K Buy
5,368
+1,450
+37% +$120K 0.32% 92
2022
Q4
$336K Buy
+3,918
New +$310K 0.22% 89

Other funds holding GILD

Western Financial Corp's GILD Position: Q2 2026 in Review

Western Financial Corp increased its Gilead Sciences (GILD) stake by 6.5% in Q2 2026, buying an estimated $39.1K and bringing the position to 4,860 shares worth $614K. The position accounts for 0.18% of the portfolio, ranked #91.

Western Financial Corp first reported a position in GILD in Q4 2022 and has held it in 9 quarters since. The position peaked at $1.11M in Q1 2025. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Western Financial Corp held 4,860 shares of Gilead Sciences worth $614K as of Q2 2026.
  • Western Financial Corp bought 297 Gilead Sciences shares in Q2 2026, an estimated $39.1K.
  • Gilead Sciences made up 0.18% of Western Financial Corp's portfolio in Q2 2026, its #91 holding.
  • Western Financial Corp first reported a position in Gilead Sciences in Q4 2022 and has held it in 9 quarters since.
  • Western Financial Corp's Gilead Sciences position peaked at $1.11M in Q1 2025.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Western Financial Corp's 13F filing for Q2 2026, filed 22 Jul 2026.